Use of PET imaging in neuro-oncological surgery

A Holzgreve, NL Albert, N Galldiks, B Suchorska - Cancers, 2021 - mdpi.com
Simple Summary The use of positron emission tomography (PET) imaging in neuro-
oncological surgery is an exciting field with thriving perspectives. Increasing evidence exists …

Current trends in the use of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET) in neurooncology

C Stegmayr, G Stoffels, C Filss, A Heinzel… - Nuclear medicine and …, 2021 - Elsevier
The diagnostic potential of PET using the amino acid analogue O-(2-[18 F] fluoroethyl)-L-
tyrosine ([18 F] FET) in brain tumor diagnostics has been proven in many studies during the …

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics

Z Li, L Kaiser, A Holzgreve, VC Ruf… - European journal of …, 2021 - Springer
Purpose To evaluate radiomic features extracted from standard static images (20–40 min pi),
early summation images (5–15 min pi), and dynamic [18 F] FET PET images for the …

Impact of 18F-FET PET/MRI on clinical management of brain tumor patients

C Brendle, C Maier, B Bender… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Multiparametric PET/MRI with the amino-acid analog O-(2-18F-fluoroethyl)-l-tyrosine (18F-
FET) enables the simultaneous assessment of molecular, morphologic, and functional brain …

Static 18F-FET PET and DSC-PWI based on hybrid PET/MR for the prediction of gliomas defined by IDH and 1p/19q status

S Song, L Wang, H Yang, Y Shan, Y Cheng, L Xu… - European …, 2021 - Springer
Objectives To investigate the predictive value of static O-(2-18 F-fluoroethyl)-L-tyrosine
positron emission tomography (18 F-FET PET) and cerebral blood volume (CBV) for glioma …

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and …

E Bumes, FP Wirtz, C Fellner, J Grosse, D Hellwig… - Cancers, 2020 - mdpi.com
Simple Summary Approximately 75–80% of according to the classification of world health
organization (WHO) grade II and III gliomas are characterized by a mutation of the isocitrate …

Dynamic amino-acid PET in neuro-oncology: a prognostic tool becomes essential

A Verger, L Imbert, T Zaragori - European Journal of Nuclear Medicine and …, 2021 - Springer
Amino-acid PET imaging is an efficient complementary tool to MRI for the assessment of
gliomas, principally for high-grade gliomas [1] and is now recommended by the Response …

Prediction of Glioma Grade and IDH Status Using 18F-FET PET/CT Dynamic and Multiparametric Texture Analysis

R Hajri, M Nicod-Lalonde, AF Hottinger, JO Prior… - Diagnostics, 2023 - mdpi.com
Mutations in isocitrate dehydrogenase (IDH) represent an independent predictor of better
survival in patients with gliomas. We aimed to assess grade and IDH mutation status in …

PSMA PET imaging in glioblastoma: a preclinical evaluation and theranostic outlook

MA Kirchner, A Holzgreve, M Brendel, M Orth… - Frontiers in …, 2021 - frontiersin.org
Background Prostate specific membrane antigen (PSMA) PET imaging has recently gained
attention in glioblastoma (GBM) patients as a potential theranostic target for PSMA …

PET radiotracers in glioma: a review of clinical indications and evidence

A Castello, M Castellani, L Florimonte… - Clinical and …, 2022 - Springer
Purpose Over the last years, positron emission tomography/computed tomography (PET/CT)
has played a critical role in the evaluation of patients with brain tumors. Our review …